Therefore, in order to generate a gene signature with which to interrogate tumor microarrays for loss of REST function, we first sought to identify a set of REST target genes that are coordinately up-regulated when REST function is lost in multiple cell types, including tumorigenic and non-tumorigenic breast cells. The gene discussed is REST; the disease is neoplasm.